|
MLH3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.317400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.041800E-01 |
| Normal-vs-Stage2 |
5.118800E-01 |
| Normal-vs-Stage3 |
4.800000E-01 |
| Normal-vs-Stage4 |
3.313200E-01 |
| Stage1-vs-Stage2 |
9.689000E-01 |
| Stage1-vs-Stage3 |
8.720400E-01 |
| Stage1-vs-Stage4 |
6.397600E-01 |
| Stage2-vs-Stage3 |
9.284800E-01 |
| Stage2-vs-Stage4 |
6.697800E-01 |
| Stage3-vs-Stage4 |
7.564200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.461400E-01 |
| Normal-vs-AfricanAmerican |
4.442600E-01 |
| Normal-vs-Asian |
4.680000E-01 |
| Caucasian-vs-AfricanAmerican |
6.044200E-01 |
| Caucasian-vs-Asian |
7.127800E-01 |
| AfricanAmerican-vs-Asian |
8.329000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.472800E-01 |
| Normal-vs-Female |
5.456800E-01 |
| Male-vs-Female |
1.029200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.524000E-01 |
| Normal-vs-Extreme_Weight |
2.083000E-01 |
| Normal-vs-Obese |
7.914800E-01 |
| Normal-vs-Extreme_Obese |
3.009800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.453600E-01 |
| Normal_Weight-vs-Obese |
2.916200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.249200E-01 |
| Extreme_Weight-vs-Obese |
1.180590E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.721400E-01 |
| Obese-vs-Extreme_Obese |
3.233800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.641200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.360600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.044240E-01 |
| Normal-vs-Age(81-100Yrs) |
4.824000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.420400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.097500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.098100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.013700E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.451700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.201000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.353600E-01 |
| Normal-VS-Type2 PRCC |
5.214200E-02 |
| Normal-VS-KIRP CIMP |
4.609800E-01 |
| Normal-VS-Unclassified PRCC |
8.567600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.536500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.689400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.731200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.217000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.073640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.273800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.750050E-02 |
| Normal-vs-N1 |
9.591000E-01 |
| Normal-vs-N2 |
2.797600E-01 |
| N0-vs-N1 |
1.243410E-01 |
| N0-vs-N2 |
8.613000E-01 |
| N1-vs-N2 |
4.499600E-01 |
|
|
